
    
      This multicenter prospective patient registry was developed with the aim of documenting how
      surgeons are utilizing NanoBone products in foot and ankle surgery along with relevant
      patient outcomes. These outcomes include radiographic measures such as fusion or graft
      consolidation success, instrumentation integrity, and clinical outcomes (symptom and function
      improvement) based on investigator and patient-based outcome assessments.

      The primary objective of this study is to document and analyze the use of NanoBone products
      in foot and ankle surgery (as a stand-alone bone graft, no other local bone, autograft, bone
      graft substitute, or biologic product used) and determine both radiographic success and
      clinical outcomes. All product related adverse events will be documented, tabulated, and
      summarized.
    
  